BioAge

BioAge is a private biotechnology company dedicated to developing proprietary drugs to treat aging and age-related diseases.BioAge's platform identifies key drug targets that impact aging. The company's proprietary human aging cohort collected blood samples, participant omics data, and extensive medical follow-up records 45 years ago, including detailed future health spans, lifespans, and disease outcomes.BioAge has built a systems biology and AI platform that leverages these rich datasets to identify molecular drivers of age-related pathologies. BioAge’s therapeutic approaches targeting these critical pathways will address the significant unmet medical needs brought on by an aging population.